AB. Grosset, JE. Allen; GM. Rodgers, Anticoagulation with anisindione in patients who are intolerant of warfarin., in Am J Hematol, vol. 46, n. 2, giugno 1994, pp. 138-40, PMID8172181.
Spyropoulos AC, Hayth KA, Jenkins P, Anticoagulation with anisindione in a patient with a warfarin-induced skin eruption, in Pharmacotherapy, vol. 23, n. 4, aprile 2003, pp. 533–6, PMID12680483.
Lange K, Perchuk E, Mahl M, Enzinger J, Mouratoff G, Anisindione: a new anticoagulant with unusual properties, in Am. Heart J., vol. 55, n. 1, gennaio 1958, pp. 73–9, PMID13520554.
Gibelli A, Deluterotti A, [Research on the anticoagulant action of an indandione derivative (Anisindione) with prolonged action], in Rass Int Clin Ter, vol. 44, gennaio 1964, pp. 1–8, PMID14126507.
Blaustein A, A preliminary report on the clinical use of a new anticoagulant (miradon), in N Y State J Med, vol. 58, n. 5, marzo 1958, pp. 701–2, PMID13517546.
Ballerini G, La Paglia S, [Preliminary clinical investigations on a new indandione type anticoagulant: anisindione], in Prog Med (Napoli), vol. 15, n. 2, gennaio 1959, pp. 46–8, PMID13658270.
Field JB, Goldfarb MS, WAare AG, Griffith GC, Effect in man of a new indandione anticoagulant, in Proc. Soc. Exp. Biol. Med., vol. 81, n. 3, dicembre 1952, pp. 678–81, PMID13037763.
Paul HA, Arscott PM, Koppel JL, Olwin JH, Clinical experience experience with the anticoagulant anisindione (miradon), in Surg Gynecol Obstet, vol. 108, n. 5, maggio 1959, pp. 605–15, PMID13647217.
Freedman MD, Olatidoye AG, Clinically significant drug interactions with the oral anticoagulants, in Drug Saf, vol. 10, n. 5, maggio 1994, pp. 381–94, PMID8037888.
Harder S, Thürmann P, Clinically important drug interactions with anticoagulants. An update, in Clin Pharmacokinet, vol. 30, n. 6, giugno 1996, pp. 416–44, PMID8792056.